These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 35589576)

  • 21. Evidence on the prevalence, incidence, mortality and trends of human papilloma virus-associated cancers in sub-Saharan Africa: systematic scoping review.
    Lekoane KMB; Kuupiel D; Mashamba-Thompson TP; Ginindza TG
    BMC Cancer; 2019 Jun; 19(1):563. PubMed ID: 31185951
    [TBL] [Abstract][Full Text] [Related]  

  • 22. US assessment of HPV types in cancers: implications for current and 9-valent HPV vaccines.
    Saraiya M; Unger ER; Thompson TD; Lynch CF; Hernandez BY; Lyu CW; Steinau M; Watson M; Wilkinson EJ; Hopenhayn C; Copeland G; Cozen W; Peters ES; Huang Y; Saber MS; Altekruse S; Goodman MT;
    J Natl Cancer Inst; 2015 Jun; 107(6):djv086. PubMed ID: 25925419
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Temporal Trends and Projection of Cancer Attributable to Human Papillomavirus Infection in China, 2007-2030.
    Duan R; Xu K; Huang L; Yuan M; Wang H; Qiao Y; Zhao F
    Cancer Epidemiol Biomarkers Prev; 2022 May; 31(5):1130-1136. PubMed ID: 35266990
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Incidence and mortality of laryngeal cancer in China, 2014].
    Wei KR; Zheng RS; Liang ZH; Sun KX; Zhang SW; Li ZM; Zeng HM; Zou XN; Chen WQ; He J
    Zhonghua Zhong Liu Za Zhi; 2018 Oct; 40(10):736-743. PubMed ID: 30392337
    [No Abstract]   [Full Text] [Related]  

  • 25. Epidemiological dynamic modeling of human papillomavirus-related diseases to assess vaccination strategies in Argentina.
    Borracci RA; Segal SV; Méndez JH
    Medicina (B Aires); 2018; 78(5):315-328. PubMed ID: 30285924
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Analysis on mortality of cervical cancer and its temporal trend in women in China, 2006-2012].
    Bao HL; Liu YN; Wang LJ; Fang LW; Cong S; Zhou MG; Wang LH
    Zhonghua Liu Xing Bing Xue Za Zhi; 2017 Jan; 38(1):58-64. PubMed ID: 28100378
    [No Abstract]   [Full Text] [Related]  

  • 27. Increased risk of second cancers at sites associated with HPV after a prior HPV-associated malignancy, a systematic review and meta-analysis.
    Gilbert DC; Wakeham K; Langley RE; Vale CL
    Br J Cancer; 2019 Jan; 120(2):256-268. PubMed ID: 30482913
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Baseline Incidence of HPV-Associated Invasive and in Situ Cancers in Germany Prior to Potential Vaccination Effects].
    Sophia Rudolph CE; Katalinic A
    Gesundheitswesen; 2019 Dec; 81(12):993-1000. PubMed ID: 29933495
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cost-effectiveness of HPV vaccination in the context of high cervical cancer incidence and low screening coverage.
    Võrno T; Lutsar K; Uusküla A; Padrik L; Raud T; Reile R; Nahkur O; Kiivet RA
    Vaccine; 2017 Nov; 35(46):6329-6335. PubMed ID: 28899625
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Cancer incidence and mortality in China, 2022].
    Zheng RS; Chen R; Han BF; Wang SM; Li L; Sun KX; Zeng HM; Wei WW; He J
    Zhonghua Zhong Liu Za Zhi; 2024 Mar; 46(3):221-231. PubMed ID: 38468501
    [No Abstract]   [Full Text] [Related]  

  • 31. Lower incidence of vaginal cancer after cervical human papillomavirus screening - long-term follow-up of Finnish randomized screening trial.
    Vahteristo M; Leinonen MK; Sarkeala T; Anttila A; Heinävaara S
    Prev Med; 2024 Aug; 185():108031. PubMed ID: 38849059
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Incidence and mortality of cervical cancer in China, 2014].
    Gu XY; Zheng RS; Sun KX; Zhang SW; Zeng HM; Zou XN; Chen WQ; He J
    Zhonghua Zhong Liu Za Zhi; 2018 Apr; 40(4):241-246. PubMed ID: 29730908
    [No Abstract]   [Full Text] [Related]  

  • 33. [Report of Cancer Incidence and Mortality in China, 2014].
    Chen WQ; Li H; Sun KX; Zheng RS; Zhang SW; Zeng HM; Zou XN; Gu XY; He J
    Zhonghua Zhong Liu Za Zhi; 2018 Jan; 40(1):5-13. PubMed ID: 29365411
    [No Abstract]   [Full Text] [Related]  

  • 34. Incidence and cost of anal, penile, vaginal and vulvar cancer in Denmark.
    Olsen J; Jørgensen TR; Kofoed K; Larsen HK
    BMC Public Health; 2012 Dec; 12():1082. PubMed ID: 23244352
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human papillomavirus infection by anatomical site among Greek men and women: a systematic review.
    Tsikis S; Hoefer L; Charnot-Katsikas A; Schneider JA
    Eur J Cancer Prev; 2016 Nov; 25(6):558-71. PubMed ID: 26628088
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Trends of two HPV-associated cancers in Massachusetts: cervical and oropharyngeal cancer.
    Cook EE; Gershman ST; Kim JJ; Tamimi RM; Klevens RM; Holmes MD
    Cancer Causes Control; 2018 May; 29(4-5):435-443. PubMed ID: 29497883
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Incidence, cost and gender differences of oropharyngeal and noncervical anogenital cancers in South Korea.
    Choi I; Lee D; Son KB; Bae S
    BMC Public Health; 2020 Jun; 20(1):1035. PubMed ID: 32600300
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevention of Human Papillomavirus Infection. Beyond Cervical Cancer: A Brief Review.
    Medeiros R; Vaz S; Rebelo T; Figueiredo-Dias M
    Acta Med Port; 2020 Mar; 33(3):198-201. PubMed ID: 32130098
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Geographic and temporal variations in the incidence of vulvar and vaginal cancers.
    Bray F; Laversanne M; Weiderpass E; Arbyn M
    Int J Cancer; 2020 Nov; 147(10):2764-2771. PubMed ID: 32410226
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Update of HPV-associated female genital cancers in the United States, 1999-2004.
    Watson M; Saraiya M; Wu X
    J Womens Health (Larchmt); 2009 Nov; 18(11):1731-8. PubMed ID: 19951205
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.